Anticorps Monoclonal anti-Amphiregulin

Amphiregulin Monoclonal Antibody for WB, IHC, Indirect ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain, porc, rat

Applications

WB, IHC, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

1A1G9

N° de cat : 66433-1-PBS

Synonymes

AREG, 1A1G9, AR, AREGB, Colorectum cell-derived growth factor



Informations sur le produit

66433-1-PBS cible Amphiregulin dans les applications de WB, IHC, Indirect ELISA et montre une réactivité avec des échantillons Humain, porc, rat

Réactivité Humain, porc, rat
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène Amphiregulin Protéine recombinante Ag8907
Nom complet amphiregulin
Masse moléculaire calculée 252 aa, 28 kDa
Poids moléculaire observé 50 kDa, 37 kDa
Numéro d’acquisition GenBankBC009799
Symbole du gène Amphiregulin/AREG
Identification du gène (NCBI) 374
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Amphiregulin (AREG) is one of the ligands of the epidermal growth factor receptor (EGFR). AREG plays a central role in mammary gland development and branching morphogenesis in organs and is expressed both in physiological and in cancerous tissues. The AREG protein is synthesized as a 252-amino acid transmembrane precursor, pro-AREG. At the plasma membrane, pro-AREG is subjected to sequential proteolytic cleavages within its ectodomain and is then released as the soluble AREG protein. Depending on the cell type and microenvironment, AREG can be produced in multiple cellular and mature forms using alternative pro-AREG cleavage sites and glycosylation motifs. Post-translastional modfications of 50-kDa pro-AREG produces a major soluble 43-kDa form, 28-, 26-, 16-kDa membrane anchored forms, and soluble 21-, 19-, and 9-kDa forms (PMID: 9642297).

{{ptg:RelatedPrimaryAntibodies}}